Vanderbilt Center for Mucosal Inflammation and Cancer

From left, Qi Liu, PhD, Lori Coburn, MD, Gregor Neuert, PhD, Keith Wilson, MD, Ken Lau, PhD, and Bennett Landman, PhD, are leading VUMC’s contribution to the “gut cell atlas” program funded by the Leona M. and Harry B. Helmsley Charitable Trust.
November 20, 2019

Grant spurs effort to map biology of Crohn’s disease

VUMC has been awarded a three-year, $3 million grant to map — in unprecedented detail — the biology of Crohn’s disease.

By Bill Snyder
March 28, 2019

Cancer prevention drug also disables H. pylori bacterium

A medicine currently being tested as a chemoprevention agent for multiple types of cancer has more than one trick in its bag when it comes to preventing stomach cancer, Vanderbilt researchers have discovered.

By Leigh MacMillan
March 17, 2017

New target for colorectal cancer

Vanderbilt investigators have discovered that activated epidermal growth factor receptor may be a target for therapies to prevent colorectal cancer development.

By VUMC News and Communications